JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Artemis Proximal Femoral Nail for Internal Fixation of Intertrochanteric Femur Fractures

Not Applicable

Recruiting

Conditions: Femoral Neck Fractures
Femoral Fracture
Intertrochanteric Fractures

Interventions: Device: Artemis Proximal Femoral Nail (PFN) implant

First Posted Date: 2022-09-29

Last Posted Date: 2025-01-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 20

Registration Number: NCT05559736

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

Recruiting

Conditions: Ischemic Stroke

First Posted Date: 2022-09-27

Last Posted Date: 2023-09-21

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 150

Registration Number: NCT05556395

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Preventing Recurrent UTI With Vaginal Estrogen

Phase 4

Active, not recruiting

Conditions: Urinary Tract Infections
Cystitis Recurrent
Recurrent Urinary Tract Infection

Interventions: Drug: Vaginal estradiol tablets

First Posted Date: 2022-09-23

Last Posted Date: 2024-10-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 50

Registration Number: NCT05551949

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Effects of Psilocybin in Obsessive Compulsive Disorder

Early Phase 1

Recruiting

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: Psilocybin

First Posted Date: 2022-09-21

Last Posted Date: 2024-05-30

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT05546658

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Reduced Opioid Prescription After Laparoscopic Hysterectomy

Not Applicable

Active, not recruiting

Conditions: Pain, Postoperative
Opioid Misuse
Opioid Use
Pain

Interventions: Drug: OxyCODONE 5 mg Oral Tablet
Drug: Acetaminophen 500 mg Tab
Drug: Ibuprofen 600 mg

First Posted Date: 2022-09-21

Last Posted Date: 2024-12-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 120

Registration Number: NCT05548582

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Suvorexant for Opioid/Stimulant Co-use

Phase 2

Completed

Conditions: Opioid Use Disorder
Stimulant Use Disorder

Interventions: Drug: Suvorexant (dual orexin receptor antagonist)
Drug: Placebo

First Posted Date: 2022-09-19

Last Posted Date: 2024-12-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 20

Registration Number: NCT05546515

Locations: 🇺🇸
Behavioral Pharmacology Research Unit at the Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Oral N-acetylcysteine for Retinitis Pigmentosa

Phase 3

Recruiting

Conditions: Retinitis Pigmentosa

Interventions: Drug: Placebo
Drug: N-acetylcysteine

First Posted Date: 2022-09-13

Last Posted Date: 2024-12-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 438

Registration Number: NCT05537220

Locations: 🇺🇸
University of California - Davis, Department of Ophthalmology & Vision Science, Davis, California, United States
🇺🇸
Stanford University, Byers Eye Institute, Stanford, California, United States
🇺🇸
Vitreo Retinal Associates, Gainesville, Florida, United States

and more 29 locations

ACHIEVE Brain Health Follow-Up Study

Phase 3

Active, not recruiting

Conditions: Hearing Loss
Aging
Cognitive Decline
Dementia
Mild Cognitive Impairment

Interventions: Other: Hearing intervention
Other: Successful aging/delayed hearing intervention

First Posted Date: 2022-09-08

Last Posted Date: 2024-11-14

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 629

Registration Number: NCT05532657

Locations: 🇺🇸
Johns Hopkins Comstock Center for Public Health Research and Prevention, Hagerstown, Maryland, United States
🇺🇸
Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States

and more 1 locations

Evaluating Buspirone to Treat Opioid Withdrawal

Phase 2

Recruiting

Conditions: Anxiety
Opioid Withdrawal
Opioid Craving
Opioid Use Disorder

Interventions: Drug: Buspirone
Drug: Placebo
Drug: Lofexidine

First Posted Date: 2022-08-23

Last Posted Date: 2025-01-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 100

Registration Number: NCT05511909

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Prone Positioning During Delayed Cord Clamping

Not Applicable

Recruiting

Conditions: Delayed Cord Clamping

Interventions: Procedure: Supine Positioning
Procedure: Prone Positioning

First Posted Date: 2022-08-19

Last Posted Date: 2024-08-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 260

Registration Number: NCT05507424

Locations: 🇺🇸
West Penn Hospital-Allegheny Health Network, Pittsburgh, Pennsylvania, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy